Cogent Biosciences, Inc. (COGT) Total liabilities 2018–2021
Cogent Biosciences, Inc. (COGT) total liabilities at each fiscal year-end, per SEC filings.
$16.2MFY2021 · since FY2018: $20.8M → $16.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $16.2M | -8.0% |
| FY2020 | $17.7M | -31.3% |
| FY2019 | $25.7M | +23.5% |
| FY2018 | $20.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice